Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-11-052898
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-27 15:24:41
Reporting Period:
2011-10-25
Filing Date:
2011-10-27
Accepted Time:
2011-10-27 15:24:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1135906 Zalicus Inc. ZLCS Pharmaceutical Preparations (2834) 043514457
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1134655 Ansbert Gadicke C/o Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1134657 Luke Evnin C/o Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1166285 Michael Steinmetz C/o Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1221595 Iii J Nicholas Simon C/o Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1249153 Dennis Henner C/o Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1252522 Nicholas Galakatos C/o Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1252525 Kurt Wheeler C/o Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-10-25 203,200 $1.02 11,950,768 No 4 S Indirect See Footnote
Common Stock Disposition 2011-10-26 78,000 $1.02 11,872,768 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. The shares were sold as follows: 168,265 by MPM BioVentures III-QP, L.P. ("BV III QP"), 11,314 by MPM BioVentures III, L.P. ("BV III"), 3,258 by MPM Asset Management Investors 2003 BVIII LLC ("AM 2003"), 5,082 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel"), 14,221 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG") and 1,060 by MPM Asset Management LLC ("MPM AM").
  2. Represents weighted average sales price. The shares were sold at prices ranging from $1.02 to $1.03. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. The shares are held as follows: 9,898,859 by BV III QP, 664,407 by BV III, 191,356 by AM 2003, 297,962 by BV Parallel, 835,329 by BV KG and 62,855 by MPM AM. MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III and BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the members of MPM III LLC and AM 2003. Luke Evnin and Ansbert Gadicke are members of MPM AM. Each reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his or its respective pecuniary interest therein.
  4. The shares were sold as follows: 64,589 by BV III QP, 4,343 by BV III, 1,251 by AM 2003, 1,951 by BV Parallel, 5,459 by BV KG and 407 by MPM AM.
  5. The shares are held as follows: 9,834,270 by BV III QP, 660,064 by BV III, 190,105 by AM 2003, 296,011 by BV Parallel, 829,870 by BV KG and 62,448 by MPM AM. Each reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his or its respective pecuniary interest therein.